glp-1 weight loss marketing Prescription by Algorithm: The Ethical and Legal Questions Behind Advertising Eating disorder groups are sounding

Not achieving miracle results or plateauing weight loss could lead to discontinuation of GLP-1s for some patients

Transitioning from other compounds Researchers switching from tirzepatide to retatrutide should be aware that they may experience a noticeable increase in heart rate effects due to the addition of glucagon receptor activation

Some patients experience this as low energy or fatigue, particularly between meals

102 The latter, glucagon, is a basic glucose-regulating hormone with catabolic and thermogenic actions, but it also increases glucose levels and the risk of gluconeogenesis

All patients received 5 mg of oral semaglutide once daily for the first 5 days, then received a dose of 10 mg once daily for the remaining 5 days of the study